Profesyonel çevirmenler, işletmeler, web sayfaları ve erişimin serbest olduğu çeviri havuzlarından.
aspergillus infections efficacy in aspergillosis patients with poor prognosis voriconazole has in vitro fungicidal activity against aspergillus spp.
aspergillus infekcija.preparato efektyvumas, gydant aspergilioze sergancius pacientus, kuri prognoz bloga.
aspergillus infections – efficacy in aspergillosis patients with poor prognosis voriconazole has in vitro fungicidal activity against aspergillus spp.
in vitro vorikonazolas sukelia fungicidinį poveikį aspergillus kamienams.
anidulafungin has shown fungicidal activity against candida species and activity against regions of active cell growth of the hyphae of aspergillus fumigatus.
anidulafunginas fungicidiškai veikia candida padermes ir slopina aspergillus fumigatus grybelių micelio siūlų aktyvaus ląstelių augimo sritis.
in in vitro tests, posaconazole has shown fungicidal activity against most of the approximately 7,000 strains of yeast and filamentous fungi tested.
in vitro tyrimais nustatytas pozakonazolo fungicidinis poveikis daugumai iš tirtų apie 7 000 mielių ir siūlinių grybų padermių.
in addition voriconazole shows in vitro fungicidal activity against emerging fungal pathogens, including those such as scedosporium or fusarium which have limited susceptibility to existing antifungal agents.
be to, tyrimais in vitro nustatyta, kad vaistas sukelia fungicidin poveik atsirandantiems patogeniniams grybeliams, skaitant scedosporium arba fusarium, kurie kit priesgrybelini vaist poveikiui yra jautrs tik is dalies.
the mechanism by which posaconazole exerts fungicidal action involves the selective inhibition of the enzyme lanosterol 14-demethylase (cyp51) involved in ergosterol biosynthesis in yeasts and filamentous fungi.
mechanizmą, kuriuo pozakonazolas veikia fungicidiškai, sudaro atrankinis fermento lanosterolio 14-demetilazės (cyp51), reikalingo ergosterolio biosintezei mielėse ir siūliniuose grybuose, slopinimas.
in vitro, voriconazole displays broad-spectrum antifungal activity with antifungal potency against candida species (including fluconazole resistant c. krusei and resistant strains of c. glabrata and c. albicans) and fungicidal activity against all aspergillus species tested.
tyrimai, atlikti in vitro, parod, kad vorikonazolas sukelia plat priesgrybelin poveik candida rsims (skaitant flukonazolo poveikiui atsparias c. krusei, c. glabrata ir c. albicans rsis) ir fungicidin poveik visoms aspergillus rsims.